← Open Payments lookup

MELISSA KRZUS: Open Payments

NPI 1205243524 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,094 in 44 payments from 23 companies in 2025. Trend: 2023 $1,099 · 2024 $1,706 · 2025 $1,094

Food & beverage: $1,094
CompanyPaymentsAmount
ABBVIE INC.5$117
Novartis Pharmaceuticals Corporation4$113
Stryker Corporation2$102
Celgene Corporation3$80
Astellas Pharma US Inc3$69
E.R. Squibb & Sons, L.L.C.3$66
Merck Sharp & Dohme LLC3$64
Daiichi Sankyo Inc.2$53
Exelixis Inc.2$51
Janssen Biotech, Inc.2$43

Products named: KISQALI, AUGMENT INJECTABLE, REBLOZYL, Xtandi, CABOMETYX, OPDIVO, RYBREVANT, VENCLEXTA.

Industry payments across IN — which companies pay providers there.